RESUMO
OBJECTIVE: Data regarding opioid effects on esophageal function are limited. We previously demonstrated an association between chronic opioid use and esophageal motor dysfunction characterized by esophagogastric junction outflow obstruction, distal esophageal spasm, achalasia type III, and possibly Jackhammer esophagus. Our aim was to characterize the influence of different opioids and doses on esophageal dysfunction. METHODS: Retrospective review of 225 patients prescribed oxycodone, hydrocodone, or tramadol for >3 months, who completed high-resolution manometry from 2012 to 2017. Demographic and manometric data were extracted from a prospectively maintained motility database. Frequency of opioid-induced esophageal dysfunction (OIED, defined as distal esophageal spasm, esophagogastric junction outflow obstruction, achalasia type III, or Jackhammer esophagus on high-resolution manometry, was compared among different opioids. The total 24-hour opioid doses for oxycodone, hydrocodone, and tramadol were converted to a morphine equivalent for dose effect analysis. RESULTS: OIED was present in 24% (55 of 225) of opioid users. OIED was significantly more prevalent with oxycodone or hydrocodone use compared with tramadol (31% vs 28% vs 12%, P = 0.0162), and for oxycodone alone vs oxycodone with acetaminophen (43% vs 21%, P = 0.0482). There was no difference in OIED for patients taking hydrocodone alone vs hydrocodone with acetaminophen. Patients with OIED were taking a higher median 24-hour opioid dose than those without OIED (45 vs 30 mg, P = 0.058). DISCUSSION: OIED is more prevalent in patients taking oxycodone or hydrocodone compared with tramadol. There is greater likelihood of OIED developing with higher doses. Reducing the opioid dose or changing to tramadol may reduce OIED in opioid users.
Assuntos
Analgésicos Opioides/efeitos adversos , Acalasia Esofágica/induzido quimicamente , Espasmo Esofágico Difuso/induzido quimicamente , Dor Abdominal/tratamento farmacológico , Adulto , Idoso , Analgésicos Opioides/administração & dosagem , Artralgia/tratamento farmacológico , Dor nas Costas/tratamento farmacológico , Relação Dose-Resposta a Droga , Acalasia Esofágica/fisiopatologia , Doenças do Esôfago/induzido quimicamente , Doenças do Esôfago/fisiopatologia , Espasmo Esofágico Difuso/fisiopatologia , Junção Esofagogástrica/fisiopatologia , Feminino , Humanos , Hidrocodona/administração & dosagem , Hidrocodona/efeitos adversos , Masculino , Manometria , Pessoa de Meia-Idade , Oxicodona/administração & dosagem , Oxicodona/efeitos adversos , Estudos Retrospectivos , Tramadol/administração & dosagem , Tramadol/efeitos adversosAssuntos
Analgésicos Opioides/efeitos adversos , Buprenorfina/efeitos adversos , Espasmo Esofágico Difuso/induzido quimicamente , Esfíncter Esofágico Inferior/efeitos dos fármacos , Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/uso terapêutico , Buprenorfina/administração & dosagem , Buprenorfina/uso terapêutico , Transtornos de Deglutição/etiologia , Feminino , Humanos , Dor Lombar/tratamento farmacológico , Manometria , Pessoa de Meia-Idade , Adesivo TransdérmicoAssuntos
Dor no Peito/induzido quimicamente , Circulação Coronária/efeitos dos fármacos , Espasmo Esofágico Difuso/induzido quimicamente , Isquemia Miocárdica/induzido quimicamente , Receptores de Serotonina/efeitos dos fármacos , Agonistas do Receptor de Serotonina/efeitos adversos , Sumatriptana/efeitos adversos , Idoso , Dor no Peito/diagnóstico , Contraindicações , Morte Súbita Cardíaca/etiologia , Diagnóstico Diferencial , Ecocardiografia , Eletrocardiografia , Espasmo Esofágico Difuso/diagnóstico , Esôfago/inervação , Feminino , Coração/inervação , Humanos , Masculino , Isquemia Miocárdica/diagnóstico , Cervicalgia/induzido quimicamente , Cervicalgia/diagnóstico , Limiar da Dor , Receptor 5-HT1B de Serotonina , Receptor 5-HT1D de Serotonina , Receptores de Serotonina/fisiologia , Agonistas do Receptor de Serotonina/farmacologia , Agonistas do Receptor de Serotonina/uso terapêutico , Sumatriptana/farmacologia , Sumatriptana/uso terapêutico , Vasoconstrição/efeitos dos fármacosRESUMO
A total of 394 patients with noncardiac chest pain underwent both basal esophageal manometry and combined esophageal motility and acid perfusion studies between 1986 and 1988. On basal esophageal manometry, 275 patients had a normal response, 64 patients had findings of high-amplitude peristalsis or "nut-cracker" esophagus, and 11 patients exhibited changes of diffuse esophageal spasm. Of the 275 patients who had normal findings on basal esophageal manometry, 90 patients (33%) had a positive response on combined esophageal motility and acid perfusion studies, that is, reproduction of chest pain with associated abnormal motility changes. The present study focuses on the 90 patients with acid-provoked esophageal spasm. On acid perfusion study, these 90 patients had a 46.2% rise in deglutition response and a 95% increase in duration compared with a 3.2% and a 4.3% change in values for the control group of healthy volunteers. Of the group with acid-induced spasm, 90.1% had excessive dysmotility changes (repetitive waves, multiple peaks, spontaneous or simultaneous contractions) compared with an incidence of 12.5% in the control group.